The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm-Reference-Cited by-同舟云学术

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Published:2014-04-08 Issue: Volume:21 Page:34-59
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Razavi H.¹,Waked I.²,Sarrazin C.³,Myers R. P.⁴,Idilman R.⁵,Calinas F.⁶,Vogel W.⁷,Mendes Correa M. C.⁸,Hézode C.⁹,Lázaro P.¹⁰,Akarca U.¹¹,Aleman S.¹²¹³,Balık İ.¹⁴,Berg T.¹⁵,Bihl F.¹⁶,Bilodeau M.¹⁷,Blasco A. J.¹⁰,Brandão Mello C. E.¹⁸,Bruggmann P.¹⁹,Buti M.²⁰,Calleja J. L.²¹,Cheinquer H.²²,Christensen P. B.²³,Clausen M.²⁴,Coelho H. S. M.²⁵,Cramp M. E.²⁶,Dore G. J.²⁷,Doss W.²⁸,Duberg A. S.²⁹³⁰,El-Sayed M. H.³¹,Ergör G.³²,Esmat G.²⁸,Falconer K.³³,Félix J.³⁴,Ferraz M. L. G.³⁵,Ferreira P. R.³⁶,Frankova S.³⁷,García-Samaniego J.³⁸,Gerstoft J.³⁹,Giria J. A.⁴⁰,Gonçales F. L.⁴¹,Gower E.¹,Gschwantler M.⁴²,Guimarães Pessôa M.⁴³,Hindman S. J.¹,Hofer H.⁴⁴,Husa P.⁴⁵,Kåberg M.³³,Kaita K. D. E.⁴⁶⁴⁷,Kautz A.⁴⁸,Kaymakoglu S.⁴⁹,Krajden M.⁵⁰,Krarup H.⁵¹,Laleman W.⁵²,Lavanchy D.⁵³,Marinho R. T.⁵⁴,Marotta P.⁵⁵,Mauss S.⁵⁶,Moreno C.⁵⁷,Murphy K.¹,Negro F.⁵⁸,Nemecek V.⁵⁹,Örmeci N.⁶⁰,Øvrehus A. L. H.²³,Parkes J.⁶¹,Pasini K.¹,Peltekian K. M.⁶²,Ramji A.⁶³,Reis N.⁶⁴,Roberts S. K.⁶⁵,Rosenberg W. M.⁶⁶,Roudot-Thoraval F.⁶⁷,Ryder S. D.⁶⁸,Sarmento-Castro R.⁶⁹,Semela D.⁷⁰,Sherman M.⁷¹,Shiha G. E.⁷²,Sievert W.⁷³,Sperl J.³⁷,Stärkel P.⁷⁴,Stauber R. E.⁷⁵,Thompson A. J.⁷⁶,Urbanek P.⁷⁷,Van Damme P.⁷⁸,van Thiel I.⁴⁸⁷⁹,Van Vlierberghe H.⁸⁰,Vandijck D.⁸¹,Wedemeyer H.⁸²,Weis N.⁸³,Wiegand J.¹⁴,Yosry A.²⁸,Zekry A.⁸⁴,Cornberg M.⁸²,Müllhaupt B.⁸⁵,Estes C.¹

Affiliation:

1. Center for Disease Analysis; Louisville Colorado USA

2. National Liver Institute; Menoufiya Egypt

3. J.W. Goethe University Hospital; Frankfurt Germany

4. Liver Unit; Division of Gastroenterology and Hepatology; University of Calgary; Calgary AB Canada

5. Department of Gastroenterology; Ankara University School of Medicine; Ankara Turkey

6. Gastroenterology Department; Centro Hospitalar de Lisboa Central - Hospital Santo António Capuchos; Lisboa Portugal

7. Innsbruck Medical University; Innsbruck Austria

8. School of Medicine- Universidade de São Paulo; São Paulo Brazil

9. Service d' Hépato-Gastroentérologie; Hôpital Henri Mondor; Créteil France

10. Advanced Techniques in Health Services Research (TAISS); Madrid Spain

11. Gastroenterology; Ege University; Izmir Turkey

12. Department of Medicine Huddinge; Karolinska Institutet; Stockholm Sweden

13. Department of Gastroenterology and Hepatology/Infectious Diseases; Karolinska University Hospital; Stockholm Sweden

14. Infectious Diseases; Ankara University; Ankara Turkey

15. University of Leipzig; Leipzig Germany

16. Gastroenterology Department; Ospedale Cantonale; Bellinzona Switzerland

17. Liver Unit; Department of Medicine; Université de Montréal; Montréal QC Canada

18. Department of Gastroenterology; Federal University of the State of Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Rio de Janeiro Brazil

19. Arud Centres for Addiction Medicine; Zurich Switzerland

20. Hospital Vall d'Hebron; CIBERehd; Barcelona Spain

21. Hospital Puerta de Hierro; Madrid Spain

22. Hospital das Clínicas da Universidade Federal do Rio Grande do Sul; Porto Alegre Brazil

23. Department of Infectious Diseases; Odense University Hospital; Odense Denmark

24. Region Hospital Hovedstaden; Copenhagen Denmark

25. Department of Clinical Medicine; Federal University of Rio de Janeiro; Rio de Janeiro Brazil

26. Plymouth University Peninsula Schools of Medicine and Dentistry; Plymouth UK

27. Kirby Institute; University of New South Wales; Sydney NSW Australia

28. Cairo University; Cairo Egypt

29. Department of Infectious Diseases; Örebro University Hospital; Örebro Sweden

30. School of Health and Medical Sciences; Örebro University; Örebro Sweden

31. Ain Shams University; Cairo Egypt

32. Public Health and Epidemiology; Dokuz Eylul University; Izmir Turkey

33. Unit of Infectious Diseases; Department of Medicine Huddinge; Karolinska Institutet; Karolinska University Hospital; Stockholm Sweden

34. Exigo Consultores; Alhos Vedros Portugal

35. Division of Gastroenterology; Federal University of São Paulo; São Paulo Brazil

36. Division of Infectious Disease; Federal University of São Paulo; São Paulo Brazil

37. Department of Hepatogastroenterology; Institute for Clinical and Experimental Medicine; Prague Czech Republic

38. Hospital Carlos III; CIBERehd; Madrid Spain

39. University of Copenhagen; Copenhagen Denmark

40. Direcção-Geral da Saúde; Lisboa Portugal

41. Grupo de Estudo das Hepatites; Disciplina de Doenças Infecciosas; Departamento de Clínica Médica; Faculdade de Ciências Médicas; Universidade Estadual de Campinas; UNICAMP; São Paulo Brazil

42. Department of Internal Medicine IV; Wilhelminenspital; Vienna Austria

43. Division of Gastroenterology and Hepatology; University of São Paulo School of Medicine; São Paulo Brazil

44. Division of Gastroenterology and Hepatology; Department of Internal Medicine III; Medical University of Vienna; Vienna Austria

45. Clinic of Infectious Diseases of the University Hospital Brno; Masaryk University Brno; Brno Czech Republic

46. Section of Hepatology; Department of Internal Medicine; University of Manitoba; Winnipeg MB Canada

47. Viral Hepatitis Investigative Unit; Health Sciences Centre; Winnipeg MB Canada

48. European Liver Patients Association; Sint-Truiden Belgium

49. Gastroenterology; Istanbul University; Istanbul Turkey

50. British Columbia Centre for Disease Control; University of British Columbia; Vancouver BC Canada

51. Department of Medical Gastroenterology and Section of Molecular Diagnostics; Cinical Biochemistry; Aalborg University Hospital; Aalborg Denmark

52. University Hospitals Leuven; KU Leuven; Leuven Belgium

53. Independent Consultant; Denges Switzerland

54. Gastroenterology Department; Centro Hospitalar de Lisboa Norte; Hospital Santa Maria; Lisboa Portugal

55. Division of Gastroenterology; University of Western Ontario; London ON Canada

56. Heinrich-Heine University in Duesseldorf; Dusseldorf Germany

57. Erasme University Hospital; Université Libre de Bruxelles; Brussels Belgium

58. Divisions of Gastroenterology and Hepatology and of Clinical Pathology; University Hospital; Genève Switzerland

59. National Reference Laboratory for Hepatitis; National Institute of Public Health; Prague Czech Republic

60. Gastroenterology; Ankara University; Ankara Turkey

61. University of Southhampton; Southhampton UK

62. Departments of Medicine and Surgery; Queen Elizabeth II Health Sciences Centre; Capital District Health Authority; Dalhousie University and Hepatology Services; Halifax NS Canada

63. Department of Gastroenterology; University of British Columbia; Vancouver BC Canada

64. Assembleia da República; Lisboa Portugal

65. The Alfred Hospital and Monash University; Melbourne Vic. Australia

66. Division of Medicine; UCL Institute for Liver and Digestive Health; University College London; London UK

67. Département Santé Publique; Hôpital Henri Mondor; Créteil France

68. Nottingham University Hospitals NHS Trust and Biomedical Research Unit; Nottingham UK

69. Infectious Diseases Department; Centro Hospitalar do Porto; Porto Portugal

70. Division of Gastroenterology & Hepatology; Cantonal Hospital St. Gallen; St. Gallen Switzerland

71. Toronto General Hospital; University Health Network/University of Toronto; Toronto ON Canada

72. Egyptian Liver Research Institute And Hospital; Dakahliah Egypt

73. Monash University and Monash Health; Melbourne Vic. Australia

74. Cliniques Universitaires Saint-Luc; Université Catholique de Louvain; Brussel Belgium

75. Division of Gastroenterology and Hepatology; Department of Internal Medicine; Medical University of Graz; Graz Austria

76. Department of Gastroenterology; St Vincent's Hospital and the University of Melbourne; Melbourne Vic. Australia

77. Department of Internal Medicine; 1st Faculty of Medicine; Charles University in Prague and Central Military Hospital; Prague Czech Republic

78. Universiteit Antwerpen; Antwerpen Belgium

79. Deutsche Leberhilfe e.V.; Cologne Germany

80. Ghent University Hospital; Ghent Belgium

81. Department of Health Economics & Patient Safety; Ghent University; Belgium Hasselt University; Diepenbeek Belgium

82. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

83. Copenhagen University Hospital; Hvidovre Denmark

84. St George Hospital Clinical School of Medicine and School of Medical Science; University of New South Wales; Sydney NSW Australia

85. Swiss HPB (Hepato-Pancreato-Biliary) Center and Department of Gastroenterology and Hepatology; University Hospital Zürich; Zürich Switzerland

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12248/fullpdf

Reference107 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology,2013

2. The natural history of hepatitis C;Afdhal;Semin Liver Dis,2004

3. Historical epidemiology of hepatitis C virus (HCV) in select countries;Bruggmann;J Viral Hepat,2014

4. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis;Aleman;Clin Infect Dis,2013

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis;The European Journal of Health Economics;2024-01-27

2. Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening;The Turkish Journal of Gastroenterology;2023-10-03

3. Epidemiological Modeling of the Impact of Public Health Policies on Hepatitis C: Protocol for a Gamification Tool Targeting Microelimination;JMIR Research Protocols;2023-09-25

4. Acute hepatitis C virus infection: clinical update and remaining challenges;Clinical and Molecular Hepatology;2023-07-01

5. P-21 Activated Kinases in Liver Disorders;Cancers;2023-01-16